Assembly Capital Expenditures vs Net Income Analysis

ASMB Stock  USD 16.11  0.59  3.53%   
Assembly Biosciences financial indicator trend analysis is way more than just evaluating Assembly Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Assembly Biosciences is a good investment. Please check the relationship between Assembly Biosciences Capital Expenditures and its Net Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assembly Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.

Capital Expenditures vs Net Income

Capital Expenditures vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Assembly Biosciences Capital Expenditures account and Net Income. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Assembly Biosciences' Capital Expenditures and Net Income is -0.68. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Net Income in the same time period over historical financial statements of Assembly Biosciences, assuming nothing else is changed. The correlation between historical values of Assembly Biosciences' Capital Expenditures and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of Assembly Biosciences are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Capital Expenditures i.e., Assembly Biosciences' Capital Expenditures and Net Income go up and down completely randomly.

Correlation Coefficient

-0.68
Relationship DirectionNegative 
Relationship StrengthWeak

Capital Expenditures

Capital Expenditures are funds used by Assembly Biosciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Assembly Biosciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Assembly Biosciences financial statement analysis. It represents the amount of money remaining after all of Assembly Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most indicators from Assembly Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Assembly Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assembly Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.The current year's Tax Provision is expected to grow to about 34.6 K, whereas Selling General Administrative is forecasted to decline to about 17.7 M.
 2021 2022 2023 2024 (projected)
Interest Income302K1.0M2.4M1.6M
Net Interest Income302K1.0M2.4M1.6M

Assembly Biosciences fundamental ratios Correlations

0.090.930.550.960.78-0.46-0.480.160.590.710.720.690.980.410.52-0.40.590.680.570.780.980.370.510.420.96
0.09-0.12-0.660.27-0.13-0.310.740.20.160.50.130.290.0-0.720.080.27-0.12-0.6-0.48-0.13-0.010.110.01-0.26-0.08
0.93-0.120.650.870.82-0.44-0.630.250.580.530.730.670.950.530.49-0.390.650.780.590.820.960.440.580.410.93
0.55-0.660.650.30.5-0.04-0.87-0.260.24-0.030.310.150.610.860.11-0.320.250.870.940.510.62-0.070.050.270.61
0.960.270.870.30.77-0.5-0.310.310.590.790.760.770.920.230.6-0.340.680.520.30.770.920.530.640.450.91
0.78-0.130.820.50.77-0.22-0.520.160.420.40.610.570.80.470.37-0.260.750.660.371.00.80.460.580.540.84
-0.46-0.31-0.44-0.04-0.5-0.220.16-0.13-0.96-0.45-0.31-0.33-0.43-0.14-0.430.08-0.33-0.26-0.1-0.22-0.43-0.6-0.57-0.2-0.4
-0.480.74-0.63-0.87-0.31-0.520.160.26-0.330.03-0.25-0.09-0.55-0.98-0.260.38-0.45-0.97-0.71-0.53-0.55-0.29-0.41-0.49-0.56
0.160.20.25-0.260.310.16-0.130.260.120.150.610.670.17-0.330.43-0.080.45-0.16-0.370.160.180.370.350.090.23
0.590.160.580.240.590.42-0.96-0.330.120.460.410.40.560.30.46-0.160.450.440.270.410.560.60.60.310.57
0.710.50.53-0.030.790.4-0.450.030.150.460.510.590.57-0.10.58-0.430.410.170.090.40.560.350.350.230.56
0.720.130.730.310.760.61-0.31-0.250.610.410.510.980.710.180.68-0.20.720.410.220.60.710.510.420.30.72
0.690.290.670.150.770.57-0.33-0.090.670.40.590.980.660.010.71-0.180.710.270.080.560.660.520.430.290.68
0.980.00.950.610.920.8-0.43-0.550.170.560.570.710.660.480.46-0.340.580.720.610.81.00.350.510.420.97
0.41-0.720.530.860.230.47-0.14-0.98-0.330.3-0.10.180.010.480.23-0.310.40.940.690.470.490.260.370.50.5
0.520.080.490.110.60.37-0.43-0.260.430.460.580.680.710.460.23-0.310.820.380.020.360.460.640.570.710.55
-0.40.27-0.39-0.32-0.34-0.260.080.38-0.08-0.16-0.43-0.2-0.18-0.34-0.31-0.31-0.25-0.42-0.34-0.26-0.34-0.08-0.24-0.23-0.37
0.59-0.120.650.250.680.75-0.33-0.450.450.450.410.720.710.580.40.82-0.250.560.040.750.60.770.760.80.7
0.68-0.60.780.870.520.66-0.26-0.97-0.160.440.170.410.270.720.940.38-0.420.560.730.670.730.370.50.540.73
0.57-0.480.590.940.30.37-0.1-0.71-0.370.270.090.220.080.610.690.02-0.340.040.730.380.61-0.28-0.130.130.57
0.78-0.130.820.510.771.0-0.22-0.530.160.410.40.60.560.80.470.36-0.260.750.670.380.80.460.570.540.84
0.98-0.010.960.620.920.8-0.43-0.550.180.560.560.710.661.00.490.46-0.340.60.730.610.80.360.520.430.97
0.370.110.44-0.070.530.46-0.6-0.290.370.60.350.510.520.350.260.64-0.080.770.37-0.280.460.360.90.490.38
0.510.010.580.050.640.58-0.57-0.410.350.60.350.420.430.510.370.57-0.240.760.5-0.130.570.520.90.610.56
0.42-0.260.410.270.450.54-0.2-0.490.090.310.230.30.290.420.50.71-0.230.80.540.130.540.430.490.610.56
0.96-0.080.930.610.910.84-0.4-0.560.230.570.560.720.680.970.50.55-0.370.70.730.570.840.970.380.560.56
Click cells to compare fundamentals

Assembly Biosciences Account Relationship Matchups

Assembly Biosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets339.9M283.3M191.1M101.8M136.8M130.2M
Other Current Liab13.1M13.0M7.1M7.1M6.6M5.0M
Total Current Liabilities24.4M24.4M16.1M16.3M39.2M41.2M
Total Stockholder Equity273.2M240.6M168.9M82.7M41.1M39.0M
Property Plant And Equipment Net13.8M10.7M7.2M3.9M2.7M3.0M
Net Debt(34.5M)(49.3M)(39.2M)(49.0M)(17.5M)(18.4M)
Retained Earnings(439.4M)(501.6M)(631.4M)(724.5M)(785.7M)(746.5M)
Accounts Payable1.7M4.6M2.7M2.5M461K438.0K
Cash46.7M59.4M45.6M52.4M19.8M36.5M
Non Current Assets Total57.1M58.8M36.9M4.8M3.0M2.9M
Non Currrent Assets Other1.7M6.4M1.7M78K312K296.4K
Other Assets1.7M6.4M1.7M(646.0K)(742.9K)(705.8K)
Cash And Short Term Investments274.0M216.4M146.6M91.6M130.2M99.4M
Common Stock Total Equity25K32K34K49K56.4K59.2K
Common Stock Shares Outstanding2.2M39.7M46.8M4.0M4.6M4.3M
Liabilities And Stockholders Equity339.9M283.3M191.1M101.8M136.8M130.2M
Non Current Liabilities Total42.3M18.2M6.1M2.8M56.5M62.5M
Other Current Assets5.4M13.7M14.5M4.4M300K285K
Other Stockholder Equity712.8M742.4M800.7M807.9M826.9M868.3M
Total Liab66.7M42.7M22.1M19.1M95.7M100.5M
Property Plant And Equipment Gross13.8M10.7M7.2M3.9M2.9M3.0M
Total Current Assets282.8M224.5M154.2M97.0M133.8M102.4M
Accumulated Other Comprehensive Income(201K)(270K)(419K)(803K)(81K)(85.1K)
Common Stock32K34K48K49K5K4.8K
Property Plant Equipment1.8M1.6M7.2M743K854.5K1.0M
Net Tangible Assets231.6M198.9M168.9M82.7M95.1M107.5M
Retained Earnings Total Equity(341.8M)(439.4M)(501.6M)(724.5M)(652.1M)(619.5M)
Short Term Investments227.3M157.0M101M39.2M110.4M77.4M
Capital Surpluse552.8M712.8M742.4M807.9M929.1M975.6M
Other Liab38.9M33.2M11.5M2.7M2.5M2.3M
Current Deferred Revenue5.1M6.4M9.0M2.7M30.9M32.5M
Net Receivables3.4M1.2M336K944K43K40.9K
Net Invested Capital273.2M240.6M168.9M82.7M41.1M39.0M
Net Working Capital258.3M200.1M138.1M80.7M94.6M124.0M
Capital Stock32K34K48K49K5K4.8K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Assembly Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Assembly Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Assembly Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Assembly Biosciences Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assembly Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.89)
Revenue Per Share
4.125
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.35)
Return On Equity
(1.02)
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.